ClinicalTrials.Veeva

Menu

Hemodynamic and Biological Evaluations During Reventilation Collapse in ICU (REVECOL)

U

University Hospital, Clermont-Ferrand

Status

Unknown

Conditions

Adult Patients
Arterial Line
Consent of Patients
Tracheal Intubation in ICU

Study type

Observational

Funder types

Other

Identifiers

NCT01785654
CHU-0142
DC-2012-1501

Details and patient eligibility

About

Prospective, observational clinical multicentric study in ICU; during the period surrounding the orotracheal intubation.

Full description

Main objective: to describe the characteristics of reventilation collapse: collapse rate, duration and treatment implemented

Secondary objectives:

  • identify risk factors of reventilation collapse
  • compare mortality, hemodynamic, respiratory, infectious and biological data between collapse group and no reventilation collapse group.

Enrollment

400 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Arterial line
  • Consent of patients
  • Adult patients
  • Tracheal intubation in ICU

Exclusion criteria

  • tracheal intubation for cardiac arrest
  • pregnant woman
  • major protected

Trial design

400 participants in 1 patient group

reventilation collapse

Trial contacts and locations

1

Loading...

Central trial contact

Patrick LACARIN

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems